ARTEMISMED belongs to the sector and operates within the industry. The company is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). In this detailed post, we will explore ARTEMISMED share price targets from 2025, 2026, and up to 2030. For long-term forecasts, we will use different technical analysis approaches to predict targets up to the year 2030.
For additional insights, refer to ARTEMISMED technical analysis.
To forecast the price of ARTEMISMED up to the year 2030, we will use a machine learning approach where the forecasted data is trained on past performance. Artemis Medicare Services Ltd, known for its significant presence in the Indian share market, has shown various trends over the years. In this section, we discuss ARTEMISMED's current market position, its growth trajectory, and how external market factors might influence its price performance leading up to 2030.
ARTEMISMED’s Performance Overview
Current Performance
Current stock data is not available for ARTEMISMED.
Historical Performance
Historical stock data is not available for ARTEMISMED.
ARTEMISMED for Tomorrow
Insufficient stock data to determine trends for ARTEMISMED.
ARTEMISMED Share Price Target 2025
The share price of ARTEMISMED is expected to reach a value of Rs. 258.05 by March 2025. If the Macro and Micro economic factors along with the industry trend support, we might see the target price of Artemis Medicare Services Ltd reach Rs. 422.87 by December 2025.
Month | Target |
---|---|
March 2025 target for ARTEMISMED | ₹258.05 |
April 2025 target for ARTEMISMED | ₹305.51 |
May 2025 target for ARTEMISMED | ₹319.19 |
June 2025 target for ARTEMISMED | ₹332.35 |
July 2025 target for ARTEMISMED | ₹344.83 |
August 2025 target for ARTEMISMED | ₹359.47 |
September 2025 target for ARTEMISMED | ₹375.13 |
October 2025 target for ARTEMISMED | ₹391.72 |
November 2025 target for ARTEMISMED | ₹407.91 |
December 2025 target for ARTEMISMED | ₹422.87 |
Summary of ARTEMISMED Share Price Forecast for 2025
- The initial price target for Artemis Medicare Services Ltd in 2025 is projected to be ₹258.05.
- With favorable market conditions, the mid-year price target for Artemis Medicare Services Ltd could reach ₹359.47.
- By the end of 2025, the price target for Artemis Medicare Services Ltd is expected to potentially reach ₹422.87, considering bullish market trends.
ARTEMISMED Share Price Target 2026
As per technical data, the minimum share price target of ARTEMISMED is expected to reach Rs. 439.5 and the maximum value that shares of ARTEMISMED can reach is Rs. 692.97.
Month | Target |
---|---|
January 2026 target for ARTEMISMED | ₹439.50 |
February 2026 target for ARTEMISMED | ₹458.60 |
March 2026 target for ARTEMISMED | ₹478.73 |
April 2026 target for ARTEMISMED | ₹500.65 |
May 2026 target for ARTEMISMED | ₹523.07 |
June 2026 target for ARTEMISMED | ₹544.64 |
July 2026 target for ARTEMISMED | ₹565.08 |
August 2026 target for ARTEMISMED | ₹589.08 |
September 2026 target for ARTEMISMED | ₹614.74 |
October 2026 target for ARTEMISMED | ₹641.93 |
November 2026 target for ARTEMISMED | ₹668.45 |
December 2026 target for ARTEMISMED | ₹692.97 |
Summary of ARTEMISMED Share Price Forecast for 2026
- The initial price target for Artemis Medicare Services Ltd in 2026 is projected to be ₹439.50.
- With favorable market conditions, the mid-year price target for Artemis Medicare Services Ltd could reach ₹544.64.
- By the end of 2026, the price target for Artemis Medicare Services Ltd is expected to potentially reach ₹692.97, considering bullish market trends.
ARTEMISMED Share Price Target 2027
Using Fibonacci projections, the estimated price target forecast for Artemis Medicare Services Ltd (ARTEMISMED) in the first half of the year 2027 will be between ₹720.23 - ₹892.52. By the second half of 2027, the share price of ARTEMISMED may reach a maximum value of ₹1135.59.
Month | Target |
---|---|
January 2027 target for ARTEMISMED | ₹720.23 |
February 2027 target for ARTEMISMED | ₹751.53 |
March 2027 target for ARTEMISMED | ₹784.51 |
April 2027 target for ARTEMISMED | ₹820.44 |
May 2027 target for ARTEMISMED | ₹857.17 |
June 2027 target for ARTEMISMED | ₹892.52 |
July 2027 target for ARTEMISMED | ₹926.02 |
August 2027 target for ARTEMISMED | ₹965.35 |
September 2027 target for ARTEMISMED | ₹1,007.39 |
October 2027 target for ARTEMISMED | ₹1,051.95 |
November 2027 target for ARTEMISMED | ₹1,095.41 |
December 2027 target for ARTEMISMED | ₹1,135.59 |
Summary of ARTEMISMED Share Price Forecast for 2027
- The initial price target for Artemis Medicare Services Ltd in 2027 is projected to be ₹720.23.
- With favorable market conditions, the mid-year price target for Artemis Medicare Services Ltd could reach ₹892.52.
- By the end of 2027, the price target for Artemis Medicare Services Ltd is expected to potentially reach ₹1,135.59, considering bullish market trends.
ARTEMISMED Share Price Target 2028
The share price for ARTEMISMED in 2028 could start around ₹1180.26 and potentially climb to ₹1860.94 by the end of the year, subject to overall market and sector conditions.
Month | Target |
---|---|
January 2028 target for ARTEMISMED | ₹1,180.26 |
February 2028 target for ARTEMISMED | ₹1,231.56 |
March 2028 target for ARTEMISMED | ₹1,285.60 |
April 2028 target for ARTEMISMED | ₹1,344.48 |
May 2028 target for ARTEMISMED | ₹1,404.67 |
June 2028 target for ARTEMISMED | ₹1,462.60 |
July 2028 target for ARTEMISMED | ₹1,517.51 |
August 2028 target for ARTEMISMED | ₹1,581.95 |
September 2028 target for ARTEMISMED | ₹1,650.85 |
October 2028 target for ARTEMISMED | ₹1,723.87 |
November 2028 target for ARTEMISMED | ₹1,795.09 |
December 2028 target for ARTEMISMED | ₹1,860.94 |
Summary of ARTEMISMED Share Price Forecast for 2028
- The initial price target for Artemis Medicare Services Ltd in 2028 is projected to be ₹1,180.26.
- With favorable market conditions, the mid-year price target for Artemis Medicare Services Ltd could reach ₹1,462.60.
- By the end of 2028, the price target for Artemis Medicare Services Ltd is expected to potentially reach ₹1,860.94, considering bullish market trends.
ARTEMISMED Share Price Target 2029
The share price for ARTEMISMED in 2029 could start around ₹1934.14 and potentially climb to ₹3049.58 by the end of the year, subject to overall market and sector conditions.
Month | Target |
---|---|
January 2029 target for ARTEMISMED | ₹1,934.14 |
February 2029 target for ARTEMISMED | ₹2,018.20 |
March 2029 target for ARTEMISMED | ₹2,106.75 |
April 2029 target for ARTEMISMED | ₹2,203.24 |
May 2029 target for ARTEMISMED | ₹2,301.89 |
June 2029 target for ARTEMISMED | ₹2,396.81 |
July 2029 target for ARTEMISMED | ₹2,486.79 |
August 2029 target for ARTEMISMED | ₹2,592.39 |
September 2029 target for ARTEMISMED | ₹2,705.30 |
October 2029 target for ARTEMISMED | ₹2,824.97 |
November 2029 target for ARTEMISMED | ₹2,941.67 |
December 2029 target for ARTEMISMED | ₹3,049.58 |
Summary of ARTEMISMED Share Price Forecast for 2029
- The initial price target for Artemis Medicare Services Ltd in 2029 is projected to be ₹1,934.14.
- With favorable market conditions, the mid-year price target for Artemis Medicare Services Ltd could reach ₹2,396.81.
- By the end of 2029, the price target for Artemis Medicare Services Ltd is expected to potentially reach ₹3,049.58, considering bullish market trends.
ARTEMISMED Share Price Target 2030
The share price for ARTEMISMED in 2030 could start around ₹3169.54 and potentially climb to ₹4997.45 by the end of the year, subject to overall market and sector conditions.
Month | Target |
---|---|
January 2030 target for ARTEMISMED | ₹3,169.54 |
February 2030 target for ARTEMISMED | ₹3,307.29 |
March 2030 target for ARTEMISMED | ₹3,452.40 |
April 2030 target for ARTEMISMED | ₹3,610.53 |
May 2030 target for ARTEMISMED | ₹3,772.18 |
June 2030 target for ARTEMISMED | ₹3,927.73 |
July 2030 target for ARTEMISMED | ₹4,075.19 |
August 2030 target for ARTEMISMED | ₹4,248.23 |
September 2030 target for ARTEMISMED | ₹4,433.27 |
October 2030 target for ARTEMISMED | ₹4,629.37 |
November 2030 target for ARTEMISMED | ₹4,820.62 |
December 2030 target for ARTEMISMED | ₹4,997.45 |
Summary of ARTEMISMED Share Price Forecast for 2030
- The initial price target for Artemis Medicare Services Ltd in 2030 is projected to be ₹3,169.54.
- With favorable market conditions, the mid-year price target for Artemis Medicare Services Ltd could reach ₹3,927.73.
- By the end of 2030, the price target for Artemis Medicare Services Ltd is expected to potentially reach ₹4,997.45, considering bullish market trends.
ARTEMISMED Share Price Target 2031
The share price for ARTEMISMED in 2031 could start around ₹5194.03 and potentially climb to ₹7586.3 by the end of the year, subject to overall market and sector conditions.
Month | Target |
---|---|
January 2031 target for ARTEMISMED | ₹5,194.03 |
February 2031 target for ARTEMISMED | ₹5,419.77 |
March 2031 target for ARTEMISMED | ₹5,657.57 |
April 2031 target for ARTEMISMED | ₹5,916.70 |
May 2031 target for ARTEMISMED | ₹6,181.61 |
June 2031 target for ARTEMISMED | ₹6,436.51 |
July 2031 target for ARTEMISMED | ₹6,678.15 |
August 2031 target for ARTEMISMED | ₹6,961.73 |
September 2031 target for ARTEMISMED | ₹7,264.96 |
October 2031 target for ARTEMISMED | ₹7,586.30 |
Summary of ARTEMISMED Share Price Forecast for 2031
- The initial price target for Artemis Medicare Services Ltd in 2031 is projected to be ₹5,194.03.
- With favorable market conditions, the mid-year price target for Artemis Medicare Services Ltd could reach ₹6,436.51.
- By the end of 2031, the price target for Artemis Medicare Services Ltd is expected to potentially reach ₹7,586.30, considering bullish market trends.
Key Takeaways from Forecasted Price for ARTEMISMED from 2025 to 2030
Year | Initial Target | Mid-Year Target | Year-End Target |
---|---|---|---|
2025 | ₹258.05 | ₹359.47 | ₹422.87 |
2026 | ₹439.50 | ₹544.64 | ₹692.97 |
2027 | ₹720.23 | ₹892.52 | ₹1,135.59 |
2028 | ₹1,180.26 | ₹1,462.60 | ₹1,860.94 |
2029 | ₹1,934.14 | ₹2,396.81 | ₹3,049.58 |
2030 | ₹3,169.54 | ₹3,927.73 | ₹4,997.45 |
- For Artemis Medicare Services Ltd in 2025, a bullish trend might take the stock to a mid-year target of ₹359.47, followed by a steady climb to ₹422.87.
- In 2026, a temporary decline in early months for Artemis Medicare Services Ltd is possible, with a recovery expected by mid-year, aiming for ₹544.64.
- Anticipating mixed trends for Artemis Medicare Services Ltd in 2027, with rapid movements both upward and downward, yet maintaining an overall upward trajectory towards ₹1,135.59.
- For 2028 and 2029, Artemis Medicare Services Ltd is expected to show strong and steady growth, potentially breaking past previous highs and setting new records.
- By 2030, the cumulative impact of market dynamics could lead Artemis Medicare Services Ltd to a substantial year-end target, surpassing previous expectations.
Final Words on Artemis Medicare Services Ltd (ARTEMISMED) Share Price Target up to 2030
To summarize, we have presented ARTEMISMED share price targets from 2025, 2026, and up to 2030, based on the most recent trading data and algorithms. These targets serve as potential support and resistance levels for the coming years.
It's essential to note that while these price targets are based on technical analysis, other market conditions and news could also impact the stock's performance. Therefore, these hypothetical targets should be used as guidelines and not as financial advice. Always perform your own due diligence before making any investment.
We wish you all the best in your investing endeavors! Please read the Disclaimer below.
Methodology
Our price forecasting model to analyse targets for ARTEMISMED uses detailed & data-driven methods to calculate these monthly price targets. This methodology includes the use of classic tools like long-term floor pivot point analysis, historical price performance metrics, and volatility data. Below, we outline the fundamental components and processes that constitute our forecasting model. It is important to note that these prices are based on mathematical calculations and in no way should these be used as financial advice. The stock market is dynamic, and there are so many factors that influence the prices of stocks that any mathematical model cannot cover.
Read more.